Correlation Between GlaxoSmithKline PLC and TrueCar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and TrueCar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and TrueCar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and TrueCar, you can compare the effects of market volatilities on GlaxoSmithKline PLC and TrueCar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of TrueCar. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and TrueCar.

Diversification Opportunities for GlaxoSmithKline PLC and TrueCar

-0.92
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and TrueCar is -0.92. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and TrueCar in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TrueCar and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with TrueCar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TrueCar has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and TrueCar go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and TrueCar

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 6.58 times less return on investment than TrueCar. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 2.82 times less risky than TrueCar. It trades about 0.02 of its potential returns per unit of risk. TrueCar is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  285.00  in TrueCar on August 31, 2024 and sell it today you would earn a total of  150.00  from holding TrueCar or generate 52.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  TrueCar

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
TrueCar 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in TrueCar are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, TrueCar exhibited solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and TrueCar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and TrueCar

The main advantage of trading using opposite GlaxoSmithKline PLC and TrueCar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, TrueCar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TrueCar will offset losses from the drop in TrueCar's long position.
The idea behind GlaxoSmithKline PLC ADR and TrueCar pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance